Travere Therapeutics (TVTX) EBT Margin (2014 - 2026)
Travere Therapeutics (TVTX) recorded EBT Margin of -20.64% in Q2 2026, down 9.51 percentage points from -11.13% a year earlier but up 8.23 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) EBT Margin (2014 - 2026) Analysis & Trends
On a TTM basis, Travere Therapeutics' EBT Margin came in at -11.34% as of Jun 30, 2026, up 39.31 percentage points year-over-year; for FY2025, it was -10.04%, up 127.41 percentage points from FY2024.
- Annual EBT Margin has increased for four straight years, with a five-year change of +85.15 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -137.45% in FY2024 (+121.51 pp), -258.96% in FY2023 (+43.57 pp), -302.54% in FY2022 (+1504.82 pp) and -1807.36% in FY2021 (-1712.16 pp).
- Quarterly EBT Margin has ranged from -739.75% in Q4 2021 to 15.60% in Q3 2025 over the past five years.
- On a year-over-year basis, EBT Margin rose in seven of the last eight quarters, with an average year-over-year change of +105.44 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 448.08 percentage points in Q4 2022, against a drop of 500.27 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -28.87% (Q1 2026), -16.24% (Q4 2025) and 15.60% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Travere Therapeutics | 5.80 Bn | 5.40 Bn | 167.41 Mn | -20.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.64% |
| Mar 31, 2026 | -28.87% |
| Dec 31, 2025 | -16.24% |
| Sep 30, 2025 | 15.60% |
| Jun 30, 2025 | -11.13% |
| Mar 31, 2025 | -50.39% |
| Dec 31, 2024 | -80.68% |
| Sep 30, 2024 | -87.18% |
| Jun 30, 2024 | -128.55% |
| Mar 31, 2024 | -328.15% |
| Dec 31, 2023 | -196.47% |
| Sep 30, 2023 | -240.54% |
| Jun 30, 2023 | -316.40% |
| Mar 31, 2023 | -312.37% |
| Dec 31, 2022 | -291.67% |
| Sep 30, 2022 | -298.91% |
| Jun 30, 2022 | -279.28% |
| Mar 31, 2022 | -348.94% |
| Dec 31, 2021 | -739.75% |
| Sep 30, 2021 | -52.18% |
API Access
Travere Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();